BDTX
Black Diamond Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.12
+0.95%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+6.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 29, 2026 | Kulkarni Samarth · director | A-Award | 40,000 | $1.71 |
| Jun 29, 2026 | Raman Prakash · director | A-Award | 40,000 | $1.71 |
| Jun 29, 2026 | Behbahani Ali · director | A-Award | 40,000 | $1.71 |
| Jun 29, 2026 | Menzel Garry E · director | A-Award | 40,000 | $1.71 |
| Jun 29, 2026 | Campbell Shannon · director | A-Award | 40,000 | $1.71 |
| Jun 29, 2026 | Dhingra Kapil · director | A-Award | 40,000 | $1.71 |
| Jun 22, 2026 | Raman Prakash · director | A-Award | 7,907 | $1.66 |
| Jun 22, 2026 | Behbahani Ali · director | A-Award | 8,961 | $1.66 |
| Mar 20, 2026 | Behbahani Ali · director | A-Award | 6,919 | $2.15 |
| Mar 20, 2026 | Raman Prakash · director | A-Award | 6,105 | $2.15 |
| Jan 23, 2026 | Jones Erika · officer: SEE REMARKS | A-Award | 200,000 | $2.57 |
| Jan 23, 2026 | Buck Elizabeth · officer: CHIEF SCIENTIFIC OFFICER | A-Award | 250,000 | $2.57 |
| Jan 23, 2026 | Velleca Mark A. · director, officer: PRESIDENT & CEO | A-Award | 600,000 | $2.57 |
| Jan 23, 2026 | Hatzis-Schoch Brent · officer: SEE REMARKS | A-Award | 250,000 | $2.57 |
| Jan 23, 2026 | Yurasov Sergey · officer: CHIEF MEDICAL OFFICER | A-Award | 250,000 | $2.57 |
| Dec 15, 2025 | Raman Prakash · director | A-Award | 4,665 | $2.76 |
| Dec 15, 2025 | Behbahani Ali · director | A-Award | 5,208 | $2.76 |
| Sep 22, 2025 | Raman Prakash · director | A-Award | 3,843 | $3.35 |
| Sep 22, 2025 | Behbahani Ali · director | A-Award | 4,291 | $3.35 |
| Jun 20, 2025 | Behbahani Ali · director | A-Award | 6,170 | $2.33 |
| Jun 20, 2025 | Raman Prakash · director | A-Award | 5,526 | $2.33 |
| Jun 12, 2025 | Campbell Shannon · director | A-Award | 30,550 | $2.43 |
| Jun 12, 2025 | Raman Prakash · director | A-Award | 30,550 | $2.43 |
| Jun 12, 2025 | Menzel Garry E · director | A-Award | 30,550 | $2.43 |
| Jun 12, 2025 | Kulkarni Samarth · director | A-Award | 30,550 | $2.43 |
| Jun 12, 2025 | Dhingra Kapil · director | A-Award | 30,550 | $2.43 |
| Jun 12, 2025 | Behbahani Ali · director | A-Award | 30,550 | $2.43 |
| Mar 21, 2025 | Behbahani Ali · director | A-Award | 7,646 | $1.88 |
| Mar 21, 2025 | Raman Prakash · director | A-Award | 6,848 | $1.88 |
| Mar 20, 2025 | BIOTECH GROWTH N V · 10 percent owner | Sale | 500,000 | $2.12 |
Institutional positioning
13F filings over the trailing two quarters
New 49Increased 65Reduced 62Sold out 31
| Filer | Action | Shares | Filed |
|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Reduced | 10,563,103 | May 15, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 4,448,757 | May 15, 2026 |
| NEA Management Company, LLC | Unchanged | 4,448,757 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 4,028,202 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 3,917,088 | Aug 7, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 2,348,651 | May 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Unchanged | 2,348,651 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,125,270 | Aug 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 1,962,394 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,850,468 | May 15, 2026 |
| Defilade Capital Management, L.P. | New Position | 1,674,999 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 1,643,747 | May 14, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 1,365,384 | Aug 11, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 1,301,664 | May 7, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,218,171 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 29, 2026